Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) EBITDA: 2013-2014

Historic EBITDA for Protara Therapeutics (TARA) over the last 2 years, with Dec 2014 value amounting to -$3.3 million.

  • Protara Therapeutics' EBITDA was N/A to $7.2 million in Q4 2014 from the same period last year, while for Dec 2014 it was -$2.7 million, marking a year-over-year change of. This contributed to the annual value of -$3.3 million for FY2014, which is 52.99% up from last year.
  • Protara Therapeutics' EBITDA amounted to -$3.3 million in FY2014, which was up 52.99% from -$7.1 million recorded in FY2013.
  • Over the past 5 years, Protara Therapeutics' EBITDA peaked at -$3.3 million during FY2014, and registered a low of -$7.1 million during FY2013.
  • Over the past 2 years, Protara Therapeutics' median EBITDA value was -$5.2 million (recorded in 2013), while the average stood at -$5.2 million.
  • Data for Protara Therapeutics' EBITDA shows a peak YoY skyrocketed of 52.99% (in 2014) over the last 5 years.
  • Yearly analysis of 2 years shows Protara Therapeutics' EBITDA stood at -$7.1 million in 2013, then spiked by 52.99% to -$3.3 million in 2014.